These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23829374)

  • 21. Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens.
    Zhao J; Cochrane CS; Najeeb J; Gooden D; Sciandra C; Fan P; Lemaitre N; Newns K; Nicholas RA; Guan Z; Thaden JT; Fowler VG; Spasojevic I; Sebbane F; Toone EJ; Duncan C; Gammans R; Zhou P
    Sci Transl Med; 2023 Aug; 15(708):eadf5668. PubMed ID: 37556556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.
    Mochalkin I; Knafels JD; Lightle S
    Protein Sci; 2008 Mar; 17(3):450-7. PubMed ID: 18287278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.
    Whittington DA; Rusche KM; Shin H; Fierke CA; Christianson DW
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8146-50. PubMed ID: 12819349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of UDP-N-acetylglucosamine acyltransferase with a bound antibacterial pentadecapeptide.
    Williams AH; Immormino RM; Gewirth DT; Raetz CR
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10877-82. PubMed ID: 16835299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis.
    Jenkins RJ; Heslip KA; Meagher JL; Stuckey JA; Dotson GD
    J Biol Chem; 2014 May; 289(22):15527-35. PubMed ID: 24742680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of A. aeolicus LpxC with bound product suggests alternate deacetylation mechanism.
    Miller MD; Gao N; Ross PL; Olivier NB
    Proteins; 2015 Sep; 83(9):1706-19. PubMed ID: 26177919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shortened hydroxyacyl chains on lipid A of Escherichia coli cells expressing a foreign UDP-N-acetylglucosamine O-acyltransferase.
    Odegaard TJ; Kaltashov IA; Cotter RJ; Steeghs L; van der Ley P; Khan S; Maskell DJ; Raetz CR
    J Biol Chem; 1997 Aug; 272(32):19688-96. PubMed ID: 9242624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The active site of Escherichia coli UDP-N-acetylglucosamine acyltransferase. Chemical modification and site-directed mutagenesis.
    Wyckoff TJ; Raetz CR
    J Biol Chem; 1999 Sep; 274(38):27047-55. PubMed ID: 10480918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the LpxC deacetylase with a bound substrate-analog inhibitor.
    Coggins BE; Li X; McClerren AL; Hindsgaul O; Raetz CR; Zhou P
    Nat Struct Biol; 2003 Aug; 10(8):645-51. PubMed ID: 12833153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin.
    McClerren AL; Endsley S; Bowman JL; Andersen NH; Guan Z; Rudolph J; Raetz CR
    Biochemistry; 2005 Dec; 44(50):16574-83. PubMed ID: 16342948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LpxC inhibition: Potential and opportunities with carbohydrate scaffolds.
    Amudala S; Sumit ; Aidhen IS
    Carbohydr Res; 2024 Mar; 537():109057. PubMed ID: 38402732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide substrate recognition by UDP-N-acetylglucosamine acyltransferase (LpxA) in the first step of lipid A biosynthesis.
    Ulaganathan V; Buetow L; Hunter WN
    J Mol Biol; 2007 Jun; 369(2):305-12. PubMed ID: 17434525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.
    Mdluli KE; Witte PR; Kline T; Barb AW; Erwin AL; Mansfield BE; McClerren AL; Pirrung MC; Tumey LN; Warrener P; Raetz CR; Stover CK
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2178-84. PubMed ID: 16723580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure and activity of Francisella novicida UDP-N-acetylglucosamine acyltransferase.
    Joo SH; Chung HS
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1223-9. PubMed ID: 27545601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A high-throughput-compatible fluorescence anisotropy-based assay for competitive inhibitors of Escherichia coli UDP-N-acetylglucosamine acyltransferase (LpxA).
    Shapiro AB; Ross PL; Gao N; Livchak S; Kern G; Yang W; Andrews B; Thresher J
    J Biomol Screen; 2013 Mar; 18(3):341-7. PubMed ID: 23015018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial activities and characterization of novel inhibitors of LpxC.
    Clements JM; Coignard F; Johnson I; Chandler S; Palan S; Waller A; Wijkmans J; Hunter MG
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1793-9. PubMed ID: 12019092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Complete Pathway Model for Lipid A Biosynthesis in Escherichia coli.
    Emiola A; George J; Andrews SS
    PLoS One; 2014; 10(4):e0121216. PubMed ID: 25919634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) inhibitors: A long path explored for potent drug design.
    Kumar Pal S; Kumar S
    Int J Biol Macromol; 2023 Apr; 234():122960. PubMed ID: 36565833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design.
    Kalinin DV; Holl R
    Curr Top Med Chem; 2016; 16(21):2379-430. PubMed ID: 27072691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.